Globus Medical (GMED) Tops Q4 EPS by 2c; offers guidance

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.60, $0.02 better than the analyst estimate of $0.58. Revenue for the quarter came in at $616.53 million versus the consensus estimate of $608.17 million.

GUIDANCE:

Globus Medical sees FY2024 EPS of $2.68-$2.70, versus the consensus of $2.70. Globus Medical sees FY2024 revenue of $2.45-2.475 million, versus the consensus of $2.477 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M